STOP Heart Disease in Breast Cancer Survivors Trial
Status:
Terminated
Trial end date:
2018-05-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to to examine the effects of atorvastatin, a type of statin, on
changes to the heart among women undergoing breast cancer treatment. Atorvastatin may reduce
or eliminate the harmful effects of chemotherapy treatment to the heart tissue of breast
cancer patients.